The vaccine clinical trial is smooth that children first under

The vaccine clinical trial is smooth that children first under the age of 3 flow
It is reported ' The intersection of reporter and Zheng dexterous) In the country " 863" The special financial support of the subject is left, China CDC (Center for Disease Prevention and Control) Start 6 months old the healthy children's first type H1N1 influenza vaccine clinical trial of 35 months old formally at the beginning of December. China CDC immunity plans Liang XiaoFeng, director of centre, to say when being interviewed by staff reporter a few days ago, the children under the age of 3 flow tallly and endanger more easily infected group for first. The clinical trial aim at, obtain the intersection of age bracket and children this, inoculate first security and the intersection of immunity and getting original the intersection of appraisal and data to flow vaccine, thus offer scientific basis for confirming inoculation dosage and immune procedure of vaccine that the little age infant first flows.

According to the introduction of Liang XiaoFeng, this clinical trial adopts the international current one at random, pair is blind and setting up the method of the control group, follow agreeing and voluntary principle in the know strictly. This time the clinical proving ground is set up in Jiangsu, Hunan, Guangxi 3 provinces, test use vaccine select Beijing for use department revitalize and Shanghai Vaccine and Serum Institute with the intersection of Zhejiang and the intersection of it and yuans of 3 first type H1N1 influenza virus which enterprises produce lyse vaccine. The immune procedure that the clinical trial adopts inoculates for 2 stitches of time for 0, 21 days. Each the intersection of vaccine and clinical proving ground recruit 300 people of inoculating etc., 120 people inoculate more than 7.5 micrograms shed vaccine among them, 120 people inoculate more than 15 micrograms shed vaccine, 60 people inoculate placeboes for the control group. 3 bases plan to observe 900 people.

So far, recruiting and first needle vaccine inoculation job of the persons who have already finished inoculating smoothly of 3 bases, enter the group and observe 935 people together, among them the base of Jiangsu has already finished the second stitch vaccine inoculation. The overall incidence of bad reaction of the persons who inoculate is relatively low, have not found the serious bad reaction. It is estimated clinical experiment work will be all finished in February of 2010.



The vaccine clinical trial is smooth that children first under the age of 3 flow